| Product NDC: | 52747-900 |
| Proprietary Name: | Tandem |
| Non Proprietary Name: | Ferrous Fumarate and Polysacchride Iron Complex |
| Active Ingredient(s): | 115.2; 162 mg/1; mg/1 & nbsp; Ferrous Fumarate and Polysacchride Iron Complex |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52747-900 |
| Labeler Name: | US Pharmaceutical Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20060217 |
| Package NDC: | 52747-900-90 |
| Package Description: | 90 CAPSULE in 1 BLISTER PACK (52747-900-90) |
| NDC Code | 52747-900-90 |
| Proprietary Name | Tandem |
| Package Description | 90 CAPSULE in 1 BLISTER PACK (52747-900-90) |
| Product NDC | 52747-900 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ferrous Fumarate and Polysacchride Iron Complex |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20060217 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | US Pharmaceutical Corporation |
| Substance Name | FERROUS ASPARTO GLYCINATE; FERROUS FUMARATE |
| Strength Number | 115.2; 162 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |